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Abstract 
Background: The fermentation of lignocellulose hydrolysates to ethanol requires robust xylose‑capable Saccharo-
myces cerevisiae strains able to operate in the presence of microbial inhibitory stresses. This study aimed at developing 
industrial S. cerevisiae strains with enhanced tolerance towards pretreatment‑derived microbial inhibitors, by identify‑
ing novel gene combinations that confer resistance to multiple inhibitors (thus cumulative inhibitor resistance pheno‑
type) with minimum impact on the xylose fermentation ability. The strategy consisted of multiple sequential delta‑
integrations of double‑gene cassettes containing one gene conferring broad inhibitor tolerance (ARI1, PAD1 or TAL1) 
coupled with an inhibitor‑specific gene (ADH6, FDH1 or ICT1). The performances of the transformants were compared 
with the parental strain in terms of biomass growth, ethanol yields and productivity, as well as detoxification capaci‑
ties in a synthetic inhibitor cocktail, sugarcane bagasse hydrolysate as well as hardwood spent sulphite liquor.
Results: The first and second round of delta‑integrated transformants exhibited a trade‑off between biomass and 
ethanol yield. Transformants showed increased inhibitor resistance phenotypes relative to parental controls specifi‑
cally in fermentations with concentrated spent sulphite liquors at 40% and 80% v/v concentrations in 2% SC media. 
Unexpectedly, the xylose fermentation capacity of the transformants was reduced compared to the parental control, 
but certain combinations of genes had a minor impact (e.g. TAL1 + FDH1). The TAL1 + ICT1 combination negatively 
impacted on both biomass growth and ethanol yield, which could be linked to the ICT1 protein increasing transfor‑
mant susceptibility to weak acids and temperature due to cell membrane changes.
Conclusions: The integration of the selected genes was proven to increase tolerance to pretreatment inhibitors in 
synthetic or industrial hydrolysates, but they were limited to the fermentation of glucose. However, some gene com‑
bination sequences had a reduced impact on xylose conversion.
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Background
The increased pressure towards decreased carbon 
emissions has spurred the development of lignocellu-
lose-derived biofuels production as replacement for 
conventional fossil fuels [1, 2]. Fermentation serves as 
bioconversion to alcohols of sugar hydrolysates derived 
from polysaccharide-rich lignocellulose biomass. How-
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of lignocellulose biomass is the recalcitrant nature of the 
material to enzymatic conversion [3, 4]. Physicochemi-
cal pre-treatment is thus required to disrupt the compact 
crystalline structure and allow enzymatic access to the 
polysaccharides within, to release fermentable sugars [3, 
5, 6]. The majority of such pre-treatment methods result 
in significant quantities of degradation products being 
formed, which have inhibitory effects of subsequent bio-
logical conversions [5, 7–11].
Saccharomyces cerevisiae cannot naturally utilize 
xylose, the most abundant pentose sugar within lignocel-
lulosic hydrolysates [12–14]. Although co-fermentation 
of glucose and xylose remains a challenge, advances in 
strain development have resulted in the development 
of industrial S. cerevisiae strains with xylose-utilizing 
capacity. Through metabolic engineering, heterologous 
xylose catabolic pathways such as the fungal oxidoreduc-
tive pathway (XR-XDH) [13, 15, 16] or a bacterial xylose 
isomerase (XI) [17, 18] have been introduced into S. cer-
evisiae strains, as well combining both pathways into the 
yeast, simultaneously [14]. Recently, the industrial strain 
 CelluXTM1 [19], a xylose engineered strain with a XI 
pathway, has been developed.
Interestingly, an unanticipated phenotype that has 
emerged from xylose strain development is hyper-sensi-
tivity of the introduced heterologous metabolic pathways 
to stressful conditions [2]. Due to the inter-connectivity 
between metabolism and stress response, strain devel-
opment for lignocellulose bioconversion technologies 
have to simultaneously address both xylose utilization 
and microbial stresses [10]. Xylose engineered industrial 
strains are thus the ideal genetic background in which to 
study the impact of microbial stresses, as well as intro-
ducing stress resistance genes. Compared to the XR-XDH 
route, there is limited knowledge on XI pathway-based 
xylose utilization for genetically engineered industrial S. 
cerevisiae [20]. Furthermore, there is a lack of studies on 
the interaction of genes involved in inhibitor tolerance 
and xylose fermentation in these yeasts.
Fermentation strains are subjected to various microbial 
stresses during lignocellulose bioconversion that include 
microbial inhibitory compounds generated during phys-
icochemical pretreatment of lignocelluloses. The concen-
trations of inhibitory compounds fluctuate depending 
on both biomass composition and pretreatment method 
used [9, 11, 21]. Furans are degradation products of sug-
ars, phenolics are derived from solubilizing lignin and 
weak acids such as acetic and formic acids are formed 
during furan degradation and/or de-acetylation of hemi-
cellulose [5, 8, 22, 23]. Such microbial inhibitors nega-
tively impact growth, fermentation and xylose utilization 
ability of yeast, which results in sub-optimal ethanol 
productivity and yields [9, 10, 13, 16]. Given the toxicity 
of these compounds, studies have been undertaken to 
develop yeast strains capable of not only withstanding 
the harsh conditions associated with lignocellulosic bio-
mass fermentations, but to also generate ethanol yields 
expected in industrial processes [5, 22]. Thus, microbial 
inhibitor toxicity represents a bottle-neck in lignocel-
lulosic bioethanol production and negating these det-
rimental inhibitory effects remains to be a fundamental 
challenge [22, 24, 25].
Inhibitor resistance is characterized as a complex func-
tion of multiple genes [10, 26–29], however, relatively few 
over-expression studies have undertaken to genetically 
engineer yeast towards multiple inhibitor tolerance phe-
notypes. Typical rational design strategies are often lim-
ited to only a few genes involved in highly specific in situ 
detoxification mechanisms, resulting in strains with 
inhibitor-specific detoxification phenotypes [30–34]. 
Examples include overexpression of either TAL1, FDH1, 
or HAA1 for weak acids resistance [30, 35] and ADH6, 
ADH7 or ARI1 [36–38] for furfural detoxification mecha-
nisms, as well as PAD1 and/or FDC1 that are linked to 
phenolic detoxification [33, 34, 39]. These studies have 
several shortcomings in that (i) the majority of over-
expression studies are conducted in laboratory strains 
limiting applicability to industrial strains; (ii) strategies 
are limited by the available knowledge of the molecular 
genetic basis of resistance phenotypes gained from lab-
oratory strains; (iii) studies make use of synthetic cock-
tails to simulate industrial stresses, and (iv) very few host 
strains are proficient xylose utilizers. Thus, more research 
is required to elucidate gene interaction or synergism 
within the dynamics of inhibitor resistance phenotypes 
in industrial strains towards industrial hydrolysates. A 
cumulative strain development strategy that combines 
multiple positive gene interactions from various stress 
response pathways could significantly enhance the yeast 
stress response towards multi-inhibitor resistance phe-
notypes. As a result, this study aims to combine inhibi-
tor resistance pathways within a metabolic engineering 
approach towards the development of efficient multi-
inhibitor resistant xylose-utilizing strains.
This study explored the simultaneous overexpression 
of multiple native gene targets that confer resistance to 
weak acids, furan aldehydes and phenolic compounds 
individually, and thereby identify gene combinations 
that could generate cumulative multi-inhibitor resist-
ance phenotypes. ARI1 (NADPH-dependent alde-
hyde reductase), PAD1 (flavin prenyltransferase) and 
TAL1 (transaldolase) were selected since these genes 
have been implicated in broader multi-inhibitor resist-
ance phenotypes [32, 39, 40], whereas FPS1 (aquaglyc-
eroporin), FDH1 (formate dehydrogenase 1), ADH6 
(NADP-dependent alcohol dehydrogenase 6) and ICT1 
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(1-acylglycerol-3-phosphate O-acyltransferase) address 
specific effects attributed to weak acid [30, 41, 42], furan 
aldehyde [37] and organic solvent stresses [43], respec-
tively. The partial deletion of FPS1 and inclusion of ICT1 
allowed for the novel regulation of “membrane-modu-
lating” genes into resistance phenotypes [44]. Dual gene 
combinations were constructed to have a multi-inhibitor 
resistance gene coupled with a target-specific gene in an 
FPS1 deletion background. Not only does this approach 
allow for the introduction of genes in novel sequential 
combinations, but also the assessment of these genes in 
industrial strains exposed to industrial-like lignocellu-
lose fermentations. Ultimately, this improves the current 
understanding of in situ detoxification of lignocellulose-
derived inhibitors for the development of robust xylose-
capable S. cerevisiae industrial strains.
Results
Chemical composition of lignocellulose hydrolysate 
and SSL
Table 1 lists some of the components determined in the 
liquid fraction of steam-exploded sugarcane bagasse 
(SCB), as well as SSL from MgO acid sulphite pulping 
process of mixed hardwood feedstocks. The pretreat-
ment as well as sulphite pulping process resulted in the 
solubilization of the hemicellulosic fraction, but lignin 
was solubilized more intensely in the case of the sulphite 
process. Both liquors were composed of fermentable sug-
ars and inhibitors such as weak acids (15.7 and 6.5 g  L−1 
for SSL and SCB hydrolysate, respectively), furans (2.3 
and 2  g  L−1 for SSL and SCB hydrolysate, respectively) 
and phenolics (2  g  L−1 and 0.8  g  L−1 for SSL and SCB 
hydrolysate, respectively). In terms of carbohydrates, 
the main sugar present was xylose with values of about 
93 g  L−1 and 8.7 g  L−1 for the SSL and SCB hydrolysate, 
respectively. Literature reports xylose as the main sugar 
present in SSL liquors generated from hardwood feed-
stocks (HSSL) [11]. Also, SSL contained considerably 
more xylose than SCB hydrolysate, as well as significant 
concentrations of inhibitors, especially acetic acid (15.1 g 
 L−1, about 3 times more than SCB hydrolysate) and phe-
nolic compounds (2 g  L−1, two times more than in steam 
explosion hydrolysate). Moreover, the SSL also has other 
compounds that can act as inhibitors such as  SO2 (used 
extensively in the wine industry to limit microbial con-
tamination at lower pH values) and MgO (inhibits the 
growth of S. cerevisiae), making hardwood SSL a particu-
larly challenging lignocellulosic feedstock [11].
Strain development in lignocellulose hydrolysate 
and inhibitor tolerance assays
The multi-inhibitor-resistant strain construction strat-
egy centred on three rounds of sequential delta integra-
tion of double-gene expression cassettes to construct 
strains overexpressing selected inhibitor resistance genes 
in different combinations. Overexpression of respective 
double-gene cassettes was facilitated by homologous 
recombination of delta-integration cassettes into native 
delta sequences distributed in the parental  CelluXTM1 
yeast genome. Transformants were screened for growth 
and ethanol yield in lignocellulosic hydrolysate after each 
round of integration to select the best strains for the 
next round of transformation, with final transformants 
assayed for inhibitor tolerance phenotypes.
Before the integration of inhibitor tolerance genes 
commenced, a partial FPS1 deletion variant of S. cerevi-
siae  CelluXTM1 was generated. Eight partial FPS1 dele-
tion transformants were selected by screening for higher 
ethanol yield (g ethanol  g−1 total sugar) on 2% YPD sup-
plemented with 65% v/v sugarcane hydrolysate (Table 1). 
The best performing transformant, CelluX1∆FPS1-C5, 
yielded 0.41 g  g−1 at 169 h that showed a 5% ethanol yield 
increment to the parental  CelluXTM1 strain at 0.39 g  g−1 
(see Additional file 1: Tables S2, S3). Interestingly, strain 
CelluX1∆FPS1-C5 also exhibited an increase of 19.8% in 
formic acid detoxification and higher xylose consump-
tion at 53.6% compared to 49.8% of the parental strain. 
This partial FPS1 deletion CelluX1∆FPS1-C5 strain was 
used as the host for the first round of delta integrations.








Glucose 14.7 ± 0.02 1.04 ± 0.02 g  L−1
Xylose 92.7 ± 1.03 8.70 ± 0.06 g  L−1
Furfural 2.08 ± 0.00 1.66 ± 0.01 g  L−1
HMFa 0.21 ± 0.01 0.35 ± 0.00 g  L−1
Acetic acid 15.1 ± 0.48 5.76 ± 0.02 g  L−1
Formic acid 0.56 ± 0.01 0.74 ± 0.02 g  L−1
Cinnamic acid 72.0 ± 18.0 – mg  L−1
Ferulic acid 275 ± 21.4 33.8 ± 4.80 mg  L−1
3,4‑DHBAb 46.1 ± 9.25 516 ± 4.22 mg  L−1
3–5  DHBAb 1.05 ± 0.36 0.002 ± 0.39 g  L−1
Vanillic acid 116 ± 32.1 16.1 ± 0.56 mg  L−1
Syringic acid 308 ± 34.4 29.3 ± 0.23 mg  L−1
Vanillin 76.1 ± 9.39 135 ± 3.05 mg  L−1
Syringaldehyde 138 ± 14.1 23.1 ± 1.15 mg  L−1
Coniferaldehyde 15.9 ± 6.20 16.6 ± 0.77 mg  L−1
MgO 17.2 – g  L−1
SO2 0.6 – g  L
−1
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The results from the best transformant per gene com-
bination from the first round of delta integration are 
listed in Table 2. The first round of transformants often 
exhibited a trade-off between growth and ethanol yield 
(see Additional file 2: Figure S1). The pBKD-AA integra-
tion cassette with the ARI1 and ADH6 genes that confer 
furan resistance, in combination with partial FPS1 dele-
tion allowed for furan and weak acid resistance. Final 
ethanol yields of pBKD-AA transformants showed over-
all improvement that ranged from 0.34 to 0.38  g   g−1 as 
compared to the parental  CelluXTM1 strain at 0.33 g  g−1, 
with a maximum increase in the ethanol yield of 15.8% 
(Table 2). Partial deletion of the FPS1 gene in combina-
tion with pBKD-AA integrations proved beneficial to 
inhibitor resistance phenotype in terms of cell growth, 
as 80% of transformants displayed similar or increased 
growth (measured in absorbance) compared to the paren-
tal strain. The pBKD-AF integration cassette overexpress-
ing the ARI1 and FDH1 genes also conferred furan and 
weak acid resistance. This configuration, however, signifi-
cantly decreased the ethanol yield by 4.29–17.2%, com-
pared to the parental strain, although an improvement 
in growth was seen with AF10, showing an increment 
of 7.92% over the parental strain. The pBKD-AI integra-
tion cassette overexpressing the ARI1 and ICT1 genes 
conferred furan, organic solvent and weak acid resistance 
however, 62.5% of transformants with this configuration 
exhibited decreased growth of 12–15%. Likewise, etha-
nol yields decreased by 1–7% showing improvement for 
only one strain (AI1) with an increment of 1.25% over the 
parental reference, respectively (see Additional file 2: Fig-
ure S1).
The pBZD-PA integration cassette overexpressing the 
PAD1 and ADH6 genes and this configuration conferred 
resistance to furans, phenolics and weak acids. After the 
first round of delta integrations, the ethanol yields of the 
transformants were lower by 2–24.6% or equal to that 
of the parental strain with six transformants showing 
improved growth by 1–18.8% growth increment (see 
Additional file 2: Figure S1). The pBZD-PF cassette inte-
gration overexpresses the PAD1 and FDH1 genes that 
confer resistance to phenolics and weak acids. These 
transformants also exhibited no increases in ethanol 
yields, but showed an increase in growth by 5–31.7% for 
most of the transformants. A similar trend was observed 
in the transformants with the pBZD-PI integration cas-
sette overexpressing the PAD1 and ICT1 genes, which 
confers resistance to weak acids, phenolics and organic 
solvents. Ethanol yields were either lower or similar to 
the parental strain, whereas growth was either similar or 
higher than that of the reference strain with PI3 transfor-
mant showing a maximum growth increment of 20.9%.
The pBHD-TA integration cassette overexpresses 
the TAL1 and ADH6 genes that confer furan and weak 
acid resistance. After the first round of delta integra-
tions, the pBHD-TA transformants showed no real dif-
ferences in ethanol yields relative to the parental strain 
with only TA6 showing improvement at 3.6% ethanol 
yield increment and final growth increment of 18.6%. 
Transformants with the pBHD-TF integration cassette 
overexpressing the TAL1 and FDH1 genes conferring 
weak acid resistance exhibited similar or higher etha-
nol yields relative to parental strain with TF2 showing 
the highest increment in yield at 16.9%. The pBHD-TI 
integration cassette overexpressing the TAL1 and ICT1 
genes that confers resistance to weak acids and organic 
solvents proved to be detrimental to both the ethanol 
yield and growth as transformants exhibited significant 
decreases in both ethanol yield (8.4–35.2%) and growth 
(20.4–38.2%).
After the first stage of delta integration, the pBHD-TF 
and pBKD-AA integration cassettes generated transfor-
mants with more than 10% increment on ethanol yield 
relative to the parental strain. Therefore, these com-
binations were selected to continue into the second 
round that involved the integration of the pBHD-TF and 
Table 2 Performance of the best transformant per gene combination after 1st stage of strain development
Gene combination Strain Resistance phenotype EtOH yield % 
increment
Growth  (OD600) 
% increment
ARI + ADH6 AA6 Furans + weak acids 15.80 19.50
ARI1 + FDH1 AF10 Furans + weak acids − 5.55 7.92
ARI1 + ICT1 AI1 Furans + weak acids + organic solvents 1.25 − 12.00
PAD1 + ADH6 PA7 Phenolics + furans + weak acids − 1.97 3.40
PAD1 + FDH1 PF5 Phenolics + weak acids − 15.40 31.80
PAD1 + ICT1 PI3 Phenolics + weak acids + organic solvents − 3.58 20.90
TAL1 + ADH6 TA6 Furans + weak acids 3.60 18.60
TAL1 + FDH1 TF2 Weak acids 16.90 6.20
TAL1 + ICT1 TI10 Weak acids + organic solvents − 8.34 − 22.30
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pBKD-AA integration cassettes into S. cerevisiae AA6 
(resulting in ATF transformants) and TF2 (TFA transfor-
mants), respectively. The second round of transformants 
also resulted in a trade-off between growth and ethanol 
yield (see Additional file 2: Figure S2). Compared to the 
parental strain, 70.8% of the ATF transformants favoured 
growth with ATF13 showing an improved growth incre-
ment at 17.3%. Conversely, 58.3% of the TFA transfor-
mants exhibited increased ethanol yields. Interestingly, 
when the concentration of hydrolysate in YPDX reduced 
from 65% v/v to 50% v/v, no significant differences were 
observed in resistance phenotypes between parental 
strain and transformants, indicating possible phenotypic 
plasticity in transformants.
In the third and final round of delta integration, plas-
mid pBZD-PI was integrated into the ATF13 (AP trans-
formants) and TFA7 (TP transformants) strains, thus 
strains overexpress six genes in the FPS1 partial deletion 
background. Subsequent transformants exhibit resist-
ance to weak acids, furans and phenolic compounds. The 
strains were evaluated on growth (absorbance), fermen-
tation ability (ethanol yield) and inhibitor detoxification 
(% conversion). S. cerevisiae  CelluXTM1 was used as an 
industrial and parental reference strain, whereas ATF13 
and TFA7 were used as additional parental reference 
strains. All transformants showed a significant improve-
ment in growth compared to the parental  CelluXTM1 
strain, during fermentations with 2% SC-X media sup-
plemented with 65% v/v sugarcane hydrolysate at pH 5 
and spiked with 20 g  L−1 of furfural and 20 g  L−1 of for-
mic acid (Fig. 1A). The growth profiles of the AP and TP 
transformants surpassed the performance of the indus-
trial  CelluXTM1 strain. Interestingly, TFA7 with only two 
gene cassettes did as well as the final transformants. AP1 
and AP4 showed the highest growth  (OD600), whereas 
TP1 was the best performer from the TP transformants 
(Fig. 1A). Only AP1 and TP1 showed a significant differ-
ence in growth between 120 h versus 168 h. As expected, 
ethanol concentrations were very low, ranging from 1.6 
to 2.4  g  L−1 given the extreme toxicity of fermentation 
media (data not shown).
The transformants showed a noteworthy differ-
ence in inhibitor detoxification phenotypes for formic 
acid (present as formate in the medium at pH 5) and 
furfural (Fig.  1B). Although AP4 showed the highest 
 OD600 at 168 h, the growth could not be linked back to 
an improved inhibitor resistance phenotype. In con-
















































Fig. 1 The performance of final transformants in A 2% SC‑X supplemented with 65% v/v sugarcane hydrolysate spiked with 20 g  L−1 furfural 
and formic acid, with a straight line indicating benchmark performance of  CelluXTM1 parent and B the % conversion of inhibitors. C A spot chart 
illustrates transformant performance to various inhibitors/stressors at  OD600 (from left to right) 5,1,0.5, 0.1 and 0.01 in 2% SC only or supplemented 
with 1 g  L−1 furfural, 6 g  L−1 acetic acid and 0.8 g  L−1 formic acid, or 0.6 g  L−1 syringaldehyde, and growth at 37 °C
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phenotype with an average of 13.4% and 19% conver-
sion of formic acid (formate) and furfural, respectively, 
at 168 h (Fig.  1B).  CelluXTM1 as parental and industrial 
reference strain, however, showed poor growth and 
poor inhibitor detoxification with no formic acid con-
verted and only 3% of the furfural detoxified. TFA7 
and AP1 transformants also surpassed the parental and 
industrial reference strain with improved detoxification 
phenotypes.
The copy number of the gene inserts were determined 
via qPCR analysis. The TFA7, TP1 and AP1 transfor-
mants each have 1 insert of the TF (TAL1 + FDH1) and 
AA (ARI1 + ADH6) double-gene constructs, i.e. 1 addi-
tional copy of the native TAL1, FDH1, ARI1 and ADH6 
genes. Both TP1 and AP1 transformants also have 6 addi-
tional copies of native PAD1 and ICT1 genes (see Addi-
tional file 1: Table S4). The copies numbers of the inserts 
between the transformants were similar. However, the 
observed phenotypes of the TFA7, TP1 and AP1 transfor-
mants were different as the AP1 strain performed poorly 
compared to the more robust TFA7 and TP1 strains.
Two different assay methods were applied to evaluate 
inhibitor tolerance phenotypes, i.e. inhibitor tolerance 
plate assays (pH 4.0–4.5, no pH control) and enzymatic 
assays. Plate assays showed variations between inhibitor 
phenotypes within the three stages of strain development 
(Fig.  1C). In particular, the PI3 strain shows increased 
susceptibility to weak acid stress (6 g  L−1 acetic acid and 
0.8  g  L−1 formic acid) when no pH control was imple-
mented (pH < 5) and this phenotype was confirmed in 
AP1 and TP1 transformants with pBZD-PI inserts in the 
third round of delta integrations (Fig. 1C), although this 
integration improved resistance to the phenolic syringal-
dehyde. AP1 was the only transformant showing resist-
ance to 1  g  L−1 furfural when critical mass was present 
[45]. The in  vitro activities of detoxification enzymes 
were assayed to determine inhibitor detoxification poten-
tial of transformants. Detoxification was measured as the 
decrease in substrate, i.e. furfural, cinnamic acid or for-
mic acid due to enzymatic degradation (see Additional 
file 1: Table S5). No significant differences were observed 
between transformants and parental reference in furfural 
assays. In the cinnamic acid assays, PI3 and TP1 transfor-
mants exhibited enhanced in vivo cinnamic acid detoxifi-
cation activity. Similarly, formic assays showed AP1 and 
TP1 transformants to have enhanced formic acid detoxi-
fication phenotypes, relative to control.
Detoxification phenotypes in simulated/synthetic inhibitor 
cocktail fermentations
The TFA7, AP1 and TP1 transformants were subjected 
to fermentations in 2% SC-X media supplemented 
with either, 5  g  L−1 furfural plus 0.5  g  L−1 HMF, 6  g 
 L−1 acetic—plus 0.81 g  L−1 formic acid, or 1 g  L−1 cin-
namic acid to ascertain detoxification phenotypes of 
the gene combinations to specific microbial inhibitors 
groups. The S. cerevisiae  CelluXTM1 strain was used as 
an industrial and parental reference. The transformants 
from the first round of integration (AA6, TF2 and PI3) 
were used as secondary controls to determine if second 
and third-round delta-integrated transformants also 
exhibit phenotype from first integrations, i.e. cumula-
tive phenotypes.
In fermentations with 1 g  L−1 cinnamic acid, there were 
no differences observed between parental  CelluXTM1 
strain and TFA7 or TP1 transformants. However, the 
PI3 transformant exhibited an enhanced cinnamic acid 
detoxification phenotypes (Fig. 2A). The AA6, TFA7, AP1 
and TP1 transformants showed marked improvement 
in furfural detoxification phenotype when compared to 
parental and industrial reference strains. All transfor-
mants exhibited a decrease in the lag phase of 24 h com-
pared to the 48  h for the parental strain, with furfural 
detoxified within the said time period (Fig. 2B). At 48 h, 
transformants exhibited ethanol yields ranging from 0.25 
to 0.29 g   g−1, whereas the parental control fermentation 
yield was below 0.1 g  g−1 (Fig. 2D). Glucose was depleted 
within 48 h versus 72 h for the parental  CelluXTM1 refer-
ence strain with no significant differences in ethanol yield 
for TFA1 and AA6 strains versus the reference strain at 
72 h. No significant differences in  CelluXTM1 and TFA7 
fermentation performances were observed with weak 
acid exposure, however, this fermentation confirmed AP1 
and TP1 strains are more susceptible to weak acids due 
to the pBZD-PI insert (Fig. 2C).
Fermentations with inhibitor cocktail were conducted 
with 2% SC supplemented with an inhibitor cocktail (IC) 
based on the composition of SSL (Table 1). Blank media 
supplemented with the cocktail was used as control 
to account for the evaporation of volatiles. Two differ-
ent carbon sources were used to determine the possible 
effect the carbon source may have on resistance pheno-
types, given the sensitivity of the introduced heterolo-
gous pathways to fermentation stresses. As anticipated, 
strains showed a significant difference in observed 
inhibitor resistance phenotypes in fermentations with 
glucose and xylose versus xylose only as carbon source 
(Fig.  3). Transformants in xylose-only fermentations 
showed poor detoxification phenotypes with < 5% of 
inhibitor compounds detoxified. In fermentations with 
both glucose and xylose, differences in detoxification 
phenotypes between transformants and the  CelluXTM1 
reference strain were observed. The AP1 transformant 
outperformed strain  CelluXTM1 for furfural detoxifi-
cation, whereas the TP1 transformant outperformed 
both AP1 and  CelluXTM1 for formic acid detoxification. 
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Overall, transformants exhibit enhanced detoxification 
phenotypes compared to  CelluXTM1 parent.
Hardwood SSL fermentations and final growth rate 
of transformants
Various concentrations of untreated SSL were used to 
characterize strain performances in lignocellulose fer-
mentations in terms of consumption of glucose and 
xylose, ethanol concentration, ethanol yield and ethanol 
productivity (Table  3). In 2% SC media supplemented 
with 40% v/v concentrated SSL at pH 5.0, glucose was 
depleted within 72  h, however, xylose consumption 
was less than 10% for all strains with the AP1 transfor-
mant showing no xylose consumption. Ethanol yields at 
72 h showed that the TP1 transformant with a yield of 
0.255 g  g−1 performed better than the  CelluXTM1 strain 
with yield a of 0.228 g  g−1 (Table 3), an 11.8% increment 
in yield above parental control. In 2% SC supplemented 
with 80% v/v concentrated SSL at pH 4.5, both parental 
and transformant strains showed no growth, however, 
strains appeared to be metabolically active as seen by 
the consumption of sugars (Table 3). Glucose consump-
tion for all strains exceeded 10%, with  CelluXTM1, TFA7 
and TP1 consuming 15.1%, 15.8% and 16.3%, respec-
tively. However, ethanol concentrations remained 
below 1  g  L−1, with only  CelluXTM1, TFA7 and TP1 
strains producing ethanol, at 0.51, 0.66 and 0.48 g  L−1, 
respectively.
The growth kinetics of the final transformants were 
characterized in 2% YPDX and YPX at pH 5.0 in terms 
of consumption of glucose and xylose, ethanol con-
centration, ethanol yield, ethanol productivity, meta-
bolic ethanol yield and the maximum specific growth 
rate (µmax) (Table 3). In 2% YPDX, the TFA7 and TP1 
transformants exhibited both increased ethanol yield 
and productivity at 0.428 g  g−1 and 0.713 g  L−1  h−1 and 
0.432  g   g−1 and 0.720  g  L−1   h−1, respectively. The co-
fermentation of glucose and xylose was only reduced 
for strain API1 during YPDX fermentations, unlike the 
low xylose utilization for all strains seen in SSL (0 – 
6% xylose consumption), highlighting the pronounced 
effect of inhibitors on % xylose consumption. Further-
more, xylose consumption in 2% YPX decreased from 
100% of the reference  CelluXTM1 strain to 42.3 – 90.1% 
for transformants, indicating that the strain modifica-
tion impacted negatively on xylose consumption. This 
was confirmed in hardwood-SSL fermentations with 
xylose as the main carbon source, where transformants 
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Fig. 2 Performances of final transformants in 2% SC‑X fermentations supplemented with either, A 1 g  L−1 cinnamic acid, B 5 g  L−1 furfural or C 6 g 
 L−1 acetic and 1 g  L−1 formic acid. D The ethanol yields of various strains in 2% SC‑X fermentations supplemented with 5 g  L−1 furfural at 48 versus 
72 h
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Discussion
Efficient carbohydrate bioconversion of lignocellulose 
hydrolysates remains a challenge given the numerous 
microbial stresses and inhibitory compounds produced 
during pre-treatment, despite the progress on the devel-
opment of industrial yeast strains with the ability of co-
fermenting glucose and xylose. Overexpression of genes 
involved in detoxification of inhibitors could be beneficial 
for improving yeast tolerance. This study used a rational 
engineering strategy based on sequential delta homolo-
gous integrations of dual expression cassettes, allowing 
the introduction of several copies into the genome of 
the yeast. Novel target gene combinations were selected 
to not only modulate the cell plasma membrane against 
inhibitor influx, but also to direct intracellular detoxifica-
tion of inhibitors and strengthen carbon/xylose metabo-
lism. One copy of the FPS1 gene in a xylose-capable (XI) 
industrial strain S. cerevisiae  CelluXTM1 was deleted, 
whereas the TAL1, PAD1, FDH1, ICT1, ARI1 and ADH6 
genes were overexpressed to develop a range of multi-
inhibitor-resistant strains. The impact of gene combi-
nations on the development of cumulative inhibitor 
resistance phenotypes was evaluated.
The first step of our study was the disruption of the 
FPS1 aquaglyceroporin gene, which encodes a channel 
protein responsible for glycerol efflux and intake of ace-
tic acid. The deletion of FPS1 in industrial S. cerevisiae 
strains has proven to substantially increase both growth 
and ethanol yield (10–45% improvement) on glucose 
media under acetic acid stresses [41] and improve xylose 
fermentation as seen by 3–10% improvement on ethanol 
yield [42]. The partial deletion of the FPS1 gene in our 
study, however, resulted in a moderate increase on the 
ethanol yield (~ 5% increment), that could be ascribed 
to the partial deletion and/or differences in the genetic 
background of the strain and media (carbon source: glu-
cose and xylose; concentration of acetic acid 2.9 g/L, pH 
5).
A CelluX1∆FPS1-C5 transformant was used as recipi-
ent strain for the sequential delta integration of nine 
different gene combinations. These combinations were 
assessed for ethanol yield and biomass formation (growth 
measured at  OD600) during fermentations supplemented 
with 65% v/v sugarcane bagasse hydrolysate (Table  1). 
Compared to parental strains, there was generally a 
trade-off between the growth and the ethanol yield of the 
transformants from the first round of delta integrations 
(see Additional file  2: Figure S1). Nevertheless, some 
combinations of genes resulted in significant improve-














































Fig. 3 The % conversion of 5 g  L−1 furfural and 0.8 g  L−1 formic acid by transformants in 2% SC fermentations supplemented with synthetic IC with 
A glucose and xylose as carbon source or B xylose as only carbon source at 120 h
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while other combinations were detrimental for both 
parameters (TAL1 + ICT1) (Table  1). The benefits of 
ARI1 and ADH6 overexpression on biomass and cell 
viability have been documented [37, 46]. Similarly, our 
results are in line with those of Sanda et  al. [47] where 
the overexpression of both TAL1 and FDH1 resulted in 
improved ethanol production in xylose-fermenting labo-
ratory strains.
None of the transformants screened could ferment 
the sugars when the SCB hydrolysate concentration in 
the media was increased from 65 to 75% v/v (data not 
shown), that suggests selecting 2–3 genes to improve 
inhibitor resistance fell short of multi-inhibitor resistance 
phenotypes. Although, it is interesting to note that the 
inhibitor-specific combinations AA (ARI1 + ADH6) for 
furans and TF (TAL1 + FDH1) for weak acids were the 
only combinations to improve both ethanol yields and 
biomass in 65% v/v hydrolysate fermentations. Inhibitor-
specific combinations with different specificities may 
have a cumulative effect in constructing multi-resistance 
phenotypes. The AA and TF combinations were used in 
subsequent strain development, which resulted in strains 
with these specific gene combinations, but in alternate 
integration sequences. The PI (PAD1 + ICT1) combina-
tion was included only for the final round of integrations 
as it did not improve ethanol yields but did improve 
growth (Table 2).
The second round of delta integrations also resulted in 
a trade-off between ethanol yield and biomass growth, 
with the ATF transformants more prone towards bio-
mass (2–17% increment in 70.8% of the transformants) 
while the TFA transformants were more inclined to 
ethanol yield improvement (5–24% increment in 58.3% 
of the transformants) (see Additional file  2: Figure S2). 
It was also found that transformants presented pheno-
typic plasticity, with no differences in growth or ethanol 
yield compared to parental strain when the toxicity of the 
media was reduced. The selected transformant for the 
next round of integration, TFA7, was also able to grow in 
the presence of syringaldehyde at low cells concentration 
(Fig. 2C).
The third round of delta integration resulted in trans-
formants with different combinations of the selected six 
genes in a partial FPS1 deletion background. Of particu-
lar interest, was whether subsequent additions of inhibi-
tor-specific gene combinations had a cumulative effect or 
build-up towards multi-inhibitor resistance phenotypes. 
The performance of the final transformants was evalu-
ated during fermentations supplemented with inhibitors 
(single inhibitor or in a cocktail) and different source of 








Media pH µMax  (h−1)
g  L−1 Y P/S g  g
−1 g  L−1  h−1
YPDX t=24 h
  CelluXTM1 100 100 17.0 ± 0.13 0.424 ± 0.00 0.707 ± 0.01 82.8 5 0.572
 TFA7 100 100 17.1 ± 0.13 0.428 ± 0.00 0.713 ± 0.01 83.5 5 0.557
 AP1 100 45.7 12.2 ± 0.09 0.305 ± 0.00 0.508 ± 0.00 82.1 5 0.513
 TP1 100 100 17.3 ± 0.08 0.432 ± 0.00 0.720 ± 0.00 84.4 5 0.545
YPX t=24 h
  CelluXTM1 – 100 8.18 ± 0.05 0.396 ± 0.02 0.341 ± 0.00 77.7 5 0.412
 TFA7 – 90.1 7.52 ± 0.25 0.364 ± 0.01 0.313 ± 0.01 78.3 5 0.364
 AP1 – 42.3 3.81 ± 0.02 0.184 ± 0.00 0.159 ± 0.00 73.7 5 0.442
 TP1 – 88.5 7.47 ± 0.35 0.362 ± 0.02 0.311 ± 0.01 78.9 5 0.372
40% v/v SSL t=72 h
  CelluXTM1 100 5.8 11.6 ± 0.93 0.228 ± 0.00 0.161 ± 0.01 – 5 –
 TFA7 100 3.0 11.7 ± 0.71 0.225 ± 0.01 0.162 ± 0.01 – 5 –
 AP1 100 0 11.8 ± 1.06 0.239 ± 0.00 0.160 ± 0.02 – 5 –
 TP1 100 1.28 12.2 ± 1.17 0.255 ± 0.03 0.169 ± 0.02 – 5 –
80% v/v SSL t=241 h
  CelluXTM1 15.1 1.74 0.51 ± 0.03 n.d.a – – 4.5 –
 TFA7 15.8 1.88 0.66 ± 0.03 n.d.a – – 4.5 –
 AP1 10.6 0.76 n.d.a – – – 4.5 –
 TP1 16.3 1.55 0.48 ± 0.05 n.d.a – – 4.5 –
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sugars. The transformants were subjected to fermenta-
tions with synthetic inhibitor cocktails, as this allowed 
for a more controlled assessment to determine if phe-
notypes for specific inhibitor resistance could be linked 
to specific gene combinations. Compared to the paren-
tal strain, these transformants showed improved growth 
during fermentations supplemented with 65% v/v hydro-
lysate (Fig. 1A) and proved to be able to detoxify furfural 
and formic acid despite their high concentration in the 
media (20  g/L) (Fig.  1B). Final transformants presented 
strong furan resistance phenotypes with a 24-h reduction 
of the lag phase in synthetic media containing only fur-
fural (Fig. 2B), and improved conversion of furfural when 
the fermentations were carried out in mixed synthetic 
inhibitor cocktail with glucose and xylose (AP1, Fig. 3A).
The inclusion of the PAD1-ICT1 combination in both 
the first and the third round of integration, however, 
seemed to increase the sensitivity of the yeast towards 
weak acids at concentrations found in the sugarcane 
bagasse pretreatment liquor (Table  1), as inferred from 
the inhibitor tolerance assays (Fig.  1C) and drop in 
growth in synthetic inhibitor media containing only 
weak acids (Fig.  2C). This could explain that the TFA7 
transformant, that only contains two gene cassettes, 
was able to outperform  CelluXTM1 and, in some cases, 
TP1 and AP1 as well. Alternatively, we speculate that 
this could also be linked to a lower metabolic burden as 
compared to TP1 and AP1 (Table 3). In terms of resist-
ance towards cinnamic acids, there was no significant 
difference between the parental strain and the last set 
of transformants (Fig.  2A). In contrast, this resistance 
phenotype was evident in the first round of integration 
for the PAD1-ICT1 combo (PI3, Fig.  2A) together with 
increased susceptibility to higher temperatures (Fig. 1C). 
The reduced thermo-tolerance could be due to an excess 
fluidity of the membrane caused by a higher proportion 
of unsaturated fatty acids incorporated by the ICT1 pro-
tein (1-acylglycerol-3-phosphate O-acyltransferase) [43].
The tolerance of the yeast towards lignocellulosic-
derived inhibitors is also dependent on the carbon source 
in the fermentation media, and xylose metabolism is 
much more susceptible than glucose’s [2]. However, 
there is limited information on the possible interac-
tion between genes conferring inhibitor tolerance, and 
the genes associated with the XI pathway, especially in 
industrial strains of S. cerevisiae. Our results demon-
strate the inter-linkage between carbon metabolism and 
microbial inhibitor resistance. During fermentations with 
inhibitor cocktail media containing xylose as only carbon 
source, the conversion of furfural was decreased drasti-
cally in all the strains (Fig. 3B). However, this reduction 
was not as severe in the case of the transformants (2.4–4 
times less) compared to the parental strain (7.4 times 
less) (Fig. 3B). Invariably, the true test of inhibitor resist-
ance is fermentation ability exhibited with lignocellulose 
hydrolysates. Fermentations in SSL presented a unique 
challenge to the strain development as it is both xylose 
rich and contain microbial inhibitors unique to the paper 
and pulp production process such as lignosulfonates and 
high concentrations of  Ca+2 or  Mg+2 ions besides the 
typical compliment of weak acids, furans and phenolics 
(Table 1).
In 2% YPD supplemented with 40% v/v SSL, transfor-
mants TP1 and AP1 outperformed strain  CelluXTM1 
(4.8% increment on ethanol yield for API1, 11.84% incre-
ment on ethanol yield for TP1), confirming enhanced 
inhibitor resistance phenotypes (Table 3). Given the poor 
performances of strains in xylose-only fermentations sup-
plemented with inhibitor cocktail, it was expected that 
strains would not be able to tolerate SSL well. However, 
this improvement was observed despite a reduction in 
the xylose consumption compared to the parental strain, 
especially for the API1 transformant (Table 3). However, 
the 80% v/v SSL YPD media proved too toxic for all the 
strains, but it should be noted that the strains were spe-
cifically developed with furans, weak acids and phenolic 
compounds in mind. Hardwood-SSL contains atypical 
microbial inhibitors such as MgO, lignosulfonates and 
 SO2 which the industrial yeast strains are as yet unable to 
tolerate at such high concentrations (Table 1).
Unexpectedly, the ethanol production from xylose in 
the selected transformants was also reduced when fer-
mentations were carried out with no inhibitors present 
(Table 3, values for YPX). Nonetheless, the transformants 
containing the TAL1 + FDH1 combination from the first 
integration (TFA7, TP1) were less influenced with about 
10% reduction on xylose consumption compared to an 
almost 58% reduction in the AP1 transformant. The 
positive synergism of the overexpression of these two 
genes has been documented for a recombinant xylose-
fermenting S. cerevisiae laboratory strain, i.e. the ethanol 
production from xylose was improved, despite the media 
containing both acetic acid (1.8  g  L−1) and formic acid 
(0.96 g  L−1) [47].
Different gene interactions between gene combinations 
with no differences in gene copy numbers were observed, 
suggesting there might also have been a possible “posi-
tion effect” influencing the multi-inhibitor resistance 
phenotypes. It is tempting to speculate that the initial or 
first integration events exhibited a more dominant phe-
notype because the first cassettes integrated into highly 
active and assessable sites, whereas subsequent inte-
grations were relegated to less active areas, a so-called 
“positional effect”. As such, the transformation efficiency 
was reduced with each integration cycle. This positional 
effect could explain the higher furfural conversion of 
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API1 (Fig.  3A), and the interaction of TAL1 + FDH1 on 
xylose metabolism when the combination was the first 
integration cassette (Table 3: TFA7, TP1), as well as the 
increment of conversion of cinnamic acids only when the 
PAD1 gene was on the first integration cassette (Fig. 2A).
Additional study into advanced strain development 
strategies for the manipulation of complex phenotypes, 
such as microbial inhibitor resistance with a minimal 
detrimental impact on xylose fermentation on XI engi-
neered industrial yeasts is required. Furthermore, eluci-
dating how gene location, gene dosage and copy number 
influence exhibited phenotypes, would improve the tun-
ing of the transformation process by adjusting the DNA 
concentration and/or sequence of integration accord-
ing to genes (function, size) [48]. Combining targeted 
rational engineering with techniques such as evolution-
ary engineering or genome shuffling may pave the way 
forward in the manipulation of complex phenotypes [49].
Conclusions
The efficient conversion of sugars (glucose and xylose) in 
the presence of microbial inhibitors for lignocellulose-
derived biofuels production still remains a challenge. 
This study aimed to evaluate novel gene combinations 
that confer resistance to multiple inhibitors (cumulative 
resistance phenotypes) in recombinant xylose-capable 
industrial yeast strains. The sequential delta-integration 
of these genes resulted in strains with improved toler-
ance towards furans and formic acid, but these acquired 
abilities somehow negatively influenced the xylose con-
sumption capacity of the yeast. Nevertheless, there 
were combinations of genes where this impact was 
minimal, specifically when the sequence of integra-
tions was TAL1 + FDH1 followed by ARI1 + ADH6 (and 
PAD1 + ICT1). Despite the reduced xylose fermentation, 
selected strains could outperform the parental strain 
when grown on synthetic media supplemented with 40% 
(v/v) xylose-rich SSL hydrolysate. This study highlighted 
inhibitor resistance as a complex phenotype and contrib-
utes towards developing advanced strain development 
techniques based on positive gene interactions/mecha-
nisms to develop “hardened” multi-inhibitor resistance 
xylose-capable S. cerevisiae strains.
Materials and methods
Microbial strains and culture conditions
S. cerevisiae  CelluXTM1 (Leaf by Lesaffre, France) was 
selected as an industrial strain for rational yeast engi-
neering. S. cerevisiae  CelluXTM1 and transformants were 
routinely cultivated, selected and screened by using 
YPD (20  g  L−1 glucose, 10  g  L−1 yeast extract and 20  g 
 L−1 peptone; Merck—Darmstadt, Germany) media sup-
plemented with 300–400  µg   mL−1 of the appropriate 
antibiotics or combination of antibiotics namely; hygro-
mycin B (Calbiochem, San Diego, USA), geneticin (Mel-
ford laboratories, Ipswich, UK) and zeocin (Melford, 
Ipswich, UK). Strains were pre-cultured in synthetic 
complete (SC-X) media at pH 5 containing 20 g  L−1 glu-
cose and 20 g  L−1 xylose, 5 g  L−1  (NH4)2SO4, 1.67 g  L−1 
YNB w/o amino acids, 3  g  L−1  KH2PO4 and 100  mM 
potassium phthalate, supplemented with 20% inhibitor 
cocktail (20%-IC) containing 0.2  g  L−1 cinnamic acid, 
0.1  g  L−1 HMF, 1.5  g  L−1 furfural, 1.2  g  L−1 acetic acid 
and 0.16  g  L−1 formic acid (Sigma Aldrich, St. Louis, 
USA). Pre-cultures were incubated at 30 °C and shaking 
at 200  rpm. Growth curves of select strains were con-
ducted in YPD and YPDX (20  g  L−1 glucose, 10  g  L−1 
yeast extract, 20 g  L−1 peptone, 20 g  L−1 xylose; Merck, 
Darmstadt, Germany) media, incubated at 30  °C, shak-
ing at 200  rpm and sampled at 3-h intervals for 24  h. 
Escherichia coli DH5α (Life Technologies-CA, USA) was 
used for plasmid propagation and cloning. E.coli trans-
formants were cultivated at 37  °C in Luria–Bertani (LB) 
media (1% tryptone, 0.5% yeast extract, 1% NaCl; Merck, 
Darmstadt, Germany) supplemented with 100  µg   mL−1 
ampicillin (Roche, Johannesburg, South Africa).
Construction of plasmids
Standard protocols for DNA manipulation were fol-
lowed [50]. Genomic DNA was extracted from S. cerevi-
siae BY4742∆FPS1 [51] and used as template DNA for 
amplification of target genes open reading frame. Target 
genes ARI1, ADH6, FDH1, ICT1, PAD1, and TAL1 were 
amplified via PCR using the  Phusion® high-fidelity DNA 
polymerase (New England Biolabs, Ipswich, USA) and 
appropriate primers (Table 4) on an Applied Biosystems 
2720 thermocycler (Life Technologies, CA, USA) accord-
ing to the manufacturers’ recommendations. The primers 
introduced PacI and AscI restriction sites required for 
directional cloning into the delta-integration plasmids, 
pBZD [52], pBKD [52] and pBHD [53]. PCR products 
were initially ligated into the pCLoneJET 1.2 commercial 
vector (Thermo Scientific, Waltham, USA) according to 
the manufacturers’ guidelines. Gene sequences were veri-
fied using the dideoxy chain termination method and an 
ABI PRISM™ 3100 genetic analyser (Applied Biosystems, 
Waltham, USA) at Central Analytical Facility (CAF) of 
Stellenbosch University.
The first gene expression cassettes were constructed by 
directional cloning of ARI1, TAL1 or PAD1 into plasmids 
pBKD1, pBHD1 or pBZD1 (D1), respectively, contain-
ing the constitutive PGK1 gene promoter and termina-
tor sequences. Secondary gene expression cassettes were 
constructed by directional cloning of ADH6, FDH1 or 
ICT1 into plasmid pBKD2 (D2) containing the consti-
tutive ENO1 gene promoter and terminator sequences. 
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Double gene expression cassettes were generated by sub-
cloning the pBKD2  ENO1pt gene cassettes as a SpeI/NotI 
fragment into corresponding pB(K/H/Z)D1 plasmids to 
yield single delta plasmids with both  PGKpt and  ENOpt 
expression cassettes (see Additional file 1: Table S1). All 




The first step of the rational engineering strategy was 
to disrupt FPS1 to generate FPS1 deletion strains using 
plasmid pYFCUP1 [41]. Plasmid DNA was propagated 
and extracted using cetyltrimethylammonium bromide 
(CTAB) plasmid extraction protocol [50], and used as a 
template to amplify the FPS1L-CUP1-FPS1R insert by 
PCR using Phusion® high-fidelity DNA polymerase (New 
England Biolabs, Ipswich, USA) and appropriate prim-
ers. The 3030 bp linear PCR product was separated on 1% 
agarose gel to confirm the insert. The PCR product was 
then purified using GeneJet PCR purification kit (Thermo 
Scientific, Waltham, USA) and transformed into S. cer-
evisiae  CelluXTM1 by electroporation using a Bio-Rad 
Gene-Pulser Apparatus (1.4 kV, 200 OHMS, and 25 µF). 
Transformants were incubated in 2% YPDS (20 g  L−1 glu-
cose, 10 g  L−1 yeast extract, 20 g  L−1 peptone, 1 M sorbi-
tol) media at 30 °C for 4–5 h, plated on YPDS agar plates 
supplemented with 7  mM and 8  mM  CuSO4 and incu-
bated for 72  h at 30  °C. Successful transformants were 
confirmed with PCR using FPS1-L forward and CUP1-L 
reverse primers. Partial FPS1 deletion was confirmed and 
attributed to the aneuploidy nature of parental strain. 
The partial FPS1 deletion strains were screened in 70-mL 
fermentations using 2% YPDX supplemented with sugar-
cane pre-treatment liquor/hydrolysate to a concentration 
of 50% v/v. Fermentations were sampled at 24-h intervals 
for 7  days and samples were analysed for fermentations 
products as described in HPLC analysis sector.
Strain construction
The first round of delta integration involved the trans-
formation of nine distinct double-gene expression cas-
settes into the partial FPS1 deletion  CelluXTM1 strain. 
All integration plasmids were digested with either 
Bst11071 or XhoI (Thermo Scientific—Waltham, USA) 
according to the manufacturer recommendations and 
transformed into partial FPS1 deletion  CelluXTM1 
strain by electroporation (1.4  kV, 200 OHMS, and 25 
µF) using a Bio-Rad Gene-Pulser Apparatus. Trans-
formants were recovered on 2% YPD supplemented 
with appropriate antibiotics and confirmed via PCR 
using PGKseq-L (D1) and BKDENOpt-L (D2) as for-
ward primers in conjunction with gene-specific reverse 
primers to confirm the complete double-gene insert 
(Table  4). The transformation frequency of the delta 
plasmids allowed for a range of copies to be integrated, 
thus preliminary plate screenings were conducted to 
identify transformants with higher copy numbers. The 
plate assays were based on antibiotic resistance, i.e. 
higher copy numbers transformants exhibit increased 
Table 4 Primers used in the study
Restriction sites underlined
Gene Primer Primer 5–3′ sequence References
ADH6 ADH6‑F GCGCC TTA ATT AAATG TCT TAT CCT GAGAA This study
ADH6 ADH6‑R GTTA GGC GCG CCCTA GTC TGA AAA TTC This study
PAD1 PAD1‑F GGCC TTA ATT AAATG CTC CTA TTT CCA AGA AG This study
PAD1 PAD1‑R GATT GGC GCG CCTTA CTT GCT TTT TATT This study
ICT1 ICT1‑F GGCC TTA ATT AAATG TGG ACA AAC ACT TTC AAA TGG This study
ICT1 ICT1‑R GATT GGC GCG CCTTA CTT TGA CAG GAAC This study
ARI1 ARI1‑F GGCC TTA ATT AAATG ACT ACT GAT ACC ACT G This study
ARI1 ARI1‑R GATT GGC GCG CCTTA GGC TTC ATT T This study
FDH1 FDH1‑F GGCC TTA ATT AAATG TCG AAG GGA AAGG This study
FDH1 FDH1‑R GATC GGC GCG CCTTA TTT CTT CTG T This study
TAL1 TAL1‑F GCGC TTA ATT AAATG TCT GAA CCA GCTC This study
TAL1 TAL1‑R GATA GGC GCG CCTTA AGC GGT AAC TTTC This study
FPS1 FPS1‑L CCG AAG CTT ATG AGT AAT CCT CAA AAA GC [41]
FPS1 FPS1‑R CCA GAG CTC TCA TGT TAC CTT CTT AGC ATT [41]
CUP1 CUP1‑L CTT GGT ACC TGG GCG CTA TAC GTG CAT ATG [41]
PGK1 PGKseq‑L CTA ATT CGT AGT TTT TCA AGT TCT TAG ATG C [54]
ENO2 BKDENOpt‑L TCA GTC TAG AGC GGC CGC CTT CTA GGC GGG TTATC This study
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antibiotic resistance. The screening was done on 2% 
YPD plates supplemented with increasing concentra-
tions of appropriate antibiotics. Ten transformants 
were selected and underwent high-throughput screen-
ing to determine growth and ethanol yields. Transfor-
mants were pre-cultured in 2% YPD supplemented with 
20% v/v sugarcane hydrolysate for 24 h and inoculated 
to an optical density  (OD600) of 1 into 5 mL media com-
posed of 2% YPD supplemented with 65% v/v sugarcane 
hydrolysate. Fermentations were conducted in capped 
15-mL conical tubes incubated at 30  °C, on a rotary 
wheel at 100 rpm, for 120 h with endpoint sampling for 
fermentation products and growth  (OD600). S. cerevi-
siae  CelluXTM1 was used as a parental reference strain 
in all screening fermentations.
The second round of delta integration involved the 
integration of pBKD-AA and pBHD-TF plasmids into 
TF2 (TAL1 + FDH1) and AA6 (ARI1 + ADH6) strains, 
respectively, thus generating strains with AA and TF 
double-gene expression cassettes in different combina-
tions. Plasmids were linearized with XhoI (Thermo Sci-
entific, Waltham, USA) and transformed into selected 
strains via electroporation. Subsequently, transformants 
were recovered on 2% YPD plates supplemented with 
appropriate antibiotics and confirmed via PCR using 
appropriate primer combinations. Twenty-four con-
firmed transformants were selected for each combination 
(TF2 + pBKD-AA or AA6 + pBHD-TF) and screened in 
2% YPD supplemented with 65% v/v hydrolysate.
The final (third round) delta integration involved the 
addition of the pBZD-PI expression cassette to the sec-
ond round of gene combinations to give TF2-pBKD-
AA + pBZD-PI and AA6-pBHD-TF + pBZD-PI 
overexpression strains. Transformation efficiency 
decreased after each round of sequential integration, 
with only six strains per combination recovered and 
confirmed via PCR after the third round of integration. 
Strains were screened in 2% SC-X supplemented with 
65% v/v hydrolysate and spiked with 20  g  L−1 furfural 
and formic acid and final strains selected overexpressed 
six inhibitor resistance genes in different combinations. 
Strain names were derived from the initials of the genes 
inserted (e.g. TF is TAL1 + FDH1). For the second-round 
transformants, the initial of the second integration (D1 
gene) was added to initials of the first integration (e.g. 
TF + ARI1 resulting in TFA), whereas, for the third-
round transformants, the initial of the first integration D1 
gene and initial of the third D1 gene were combined (e.g. 
TAL1 (D1 gene first integration) + PAD1 (D1 gene third 
integration) = TP). The copy number of the introduced 
genes was determined using qPCR (service provided by 
Inqaba Biotechnical Industries (Pty) Ltd, South Africa). 
The ALG9 gene was used as housekeeping gene.
Enzymatic activity assays
Different enzyme assays were conducted to determine 
the enzymatic detoxification capacity of transformants 
as compared to the parental  CelluXTM1 strain. Trans-
formants overexpressing PAD1, ARI1, ADH6 and FDH1 
with direct enzymatic detoxification mechanisms were 
analysed in  vivo for detoxification activity using crude 
cell extract. Strains were grown on appropriate antibiotic 
selective plates for 48 h. Single colonies were suspended 
in 1  mL SC media to an  OD600 of 1 (~ 0.6  g  L−1 DW). 
Cells were harvested via centrifugation and washed first 
with PBS buffer (8.01 g  L−1 NaCl, 0.2 g  L−1 KCl, 1.78 g 
 L−1  Na2HPO4.H2O, 0.27 g  L−1  KH2PO4) followed by two 
washing steps in lysis buffer (10  mM phosphate buffer, 
2 mM EDTA, 1 mM PMSF, pH 7). After the second wash, 
100 µL glass beads (0.4 mm diameter, Sigma Aldrich, St. 
Louis USA) were added to cell pellets with 100 µL lysis 
buffer in 2-mL Eppendorf tubes and chilled on ice for 
2 min. Cells were disrupted in ten cycles with each cycle 
consisting of 1  min of vigorous vortexing followed by 
1-min cooling steps on ice. The cell extract was centri-
fuged at 13,000  rpm for 5  min at 4  °C and supernatant 
was aspirated and analysed for enzymatic activity. Alde-
hyde reductase activity was assayed according to Peters-
son et  al. [37] with modifications. The reaction mixture 
consisted of 10  mM furfural substrate and 100  µM 
NADPH cofactor in 100 mM potassium phosphate buffer 
pH 7.0. The reaction was started with the addition of 20 
µL crude cell extract and assays were incubated at 30 °C 
for 45  min. Formate dehydrogenase (FDH) activity was 
monitored according to Hasunuma et al. [30] with modi-
fications. Reaction mixture consisted of 50  mM sodium 
formate substrate and 0.4 mM NAD + cofactor in 50 mM 
potassium phosphate buffer pH 7.0. FDH reaction was 
started with the addition of 20 µL crude cell extract 
and assays were incubated at 30 °C for 45 min. Phenolic 
detoxification was determined according to Richard et al. 
[33] with adjustments. The reaction mixture consisted 
of 0.4 mM cinnamic acid substrate suspended in 20 mM 
sodium phosphate buffer pH 7.0. The reaction was ini-
tiated with the addition of 20 µL crude cell extract and 
incubated at 30 °C for 45 min. All assays were deactivated 
via acidification with the addition of 10% v/v  H2SO4 and 
stored at − 20 °C until analysis.
Inhibitor tolerance assays
The inhibitor tolerance phenotypes of transformants 
were assessed using tolerance plate assays to determine 
synergistic/antagonistic dynamics in strains containing 
the different gene expression cassettes. Transformants 
were streaked out on 2% YPD plates supplemented with 
appropriate antibiotics and incubated at 30  °C for 48  h. 
Single colonies of strains were suspended into 200 µL 2% 
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SC and suspensions were made to an  OD600 of 5, 1, 0.5, 
0.1 and 0.01. Inhibitor tolerance plates consisted of 2% 
SC agar supplemented with either 0.6  g  L−1 syringalde-
hyde, 1 g  L−1 furfural, or 6 g  L−1 acetic acid and 0.8 g  L−1 
formic acid. S. cerevisiae  CelluXTM1 was used as paren-
tal reference strain. The AA6, TF2 and PI3 strains are 
inhibitor specific for furfural, weak acids and phenolics, 
respectively, and were used as references for the pheno-
type of the first double-gene expression cassettes. Trans-
formants were spotted onto inhibitor tolerance plates (5 
µL) and incubated at 30 °C for 48–72 h. Strains were also 
cultivated on 2% SC plates and subjected to a higher tem-
perature of 37 °C as this temperature is more industrially 
relevant.
Fermentations with single inhibitor group and inhibitor 
cocktail
Fermentations were conducted in 2% SC-X minimal 
media supplemented with either; 1 g  L−1 cinnamic acid at 
pH 5.0, 5 g  L−1 furfural and 0.5 g  L−1 HMF at pH 5.0, or 
5 g  L−1 acetic acid and 0.81 g  L−1 formic acid at pH 5.0. 
Fermentations in 2% SC-X supplemented with inhibitor 
cocktail (IC) contained 6 g  L−1 acetic acid, 0.8 g  L−1 for-
mic acid, 5 g  L−1 furfural, 0.5 g  L−1 HMF and 0.5 g  L−1 
cinnamic acid. The concentration of cinnamic acid at 
0.5  g  L−1 was selected to account for the total phenolic 
content of spent sulphite liquor (SSL). Strains were pre-
cultured in 50 mL 20%-IC SC-X media pH 5.0 until late 
exponential/early stationary phase and inoculated into 
50 mL 2% SC-X or 2% SCX (xylose only) media supple-
mented with appropriate inhibitors, to an  OD600 of 1. Fer-
mentations were incubated at 30 °C, shaking at 200 rpm 
for 120 h, with sampling at 24-h intervals. Fermentations 
were inoculated in triplicate with S. cerevisiae  CelluXTM1 
as an industrial and parental reference strain. Media con-
trols were included in all fermentations to account for 
evaporation of volatile inhibitor compounds. The inhibi-
tor cocktail composition is based in part on inhibitor 
concentrations found in both SSL and sugarcane steam 
explosion liquor. Synthetic media supplemented with 
inhibitors were selected to exercise better control over 
experimental parameters given the inherent unknown/
unquantifiable mix of inhibitors present in hydrolysate/
SSL.
Lignocellulose hydrolysate and SSL fermentations
Fermentations with concentrated SSL was conducted 
to ascertain strain performance under industrially rel-
evant fermentation conditions. SSL was kindly provided 
by Sappi Saiccor (Umkomaas, South Africa) which uses 
an acid-based sulphite pulping process. Strains were 
pre-cultured in 2% SC-X media supplemented with 
20% v/v SSL to late exponential/early stationary phase 
 (OD600 > 10) and inoculated into 100-mL serum bottles 
with 50 mL fermentation media to an  OD600 of 1 (~ 0.6 g 
 L−1 DW). Fermentation media consisted of 2% SC media 
(20 g  L−1 glucose, 5 g  L−1  (NH4)2SO4, 1.67 g  L−1 YNB w/o 
aa, 3 g  L−1  KH2PO4 and 100 mM potassium phthalate), 
supplemented with either 40% (pH 5) or 80% (pH 4.5) v/v 
concentrated SSL. Samples were taken every 24  h and 
analysed via HPLC. Sugarcane hydrolysate was generated 
via steam pretreatment and pressing of pre-treated mate-
rial. First, sugarcane bagasse was water impregnated for 
24 h and dewatered using a spin dryer. The steam explo-
sion pre-treatment experiment was performed at 205 °C 
at a residence time of 13.5  min. The slurry was then 
pressed and the hydrolysate was collected, aliquot and 
frozen for storage at − 20 °C until use.
Chemical composition and analytical analysis
High-performance liquid chromatography (HPLC) was 
conducted to determine glucose, xylose, ethanol, glycerol, 
acetic acid and formic acid concentrations. Samples were 
run on an Aminex HPX-87H Column equipped with a 
Cation-H Micro-Guard Cartridge (Bio-Rad, Johannes-
burg, South Africa) at column temperature of 65 °C with 
a mobile phase of 5  mM sulphuric acid and a flow rate 
of 0.6 ml  min−1. Peaks were detected with an RI detector 
(Shodex, RI-101) operated at 45  °C. Furfural and HMF 
were analysed on a Luna C18 (2) reversed-phase column 
equipped with a Luna C18 (2) precolumn (Phenomenex). 
Mobile phases used for elution was 5 mM trifluoroacetic 
acid in water (phase A) and 5 mM trifluoroacetic acid in 
acetonitrile (phase B), the column temperature was set 
to 25  °C and the flow rate at 0.7  ml   min−1. Separation 
occurred via gradient elution, 5% mobile phase B, increas-
ing to 11% phase B over 14 min followed by an increase 
to 40% phase B over 3  min and was then kept constant 
at 40% for 2 min. This was followed by a decrease to 5% 
phase B over 5 min and ended in a final step of constant 
composition at 5% B for 4 min to equilibrate. Peaks were 
detected with a Dionex Ultimate 3000 diode array detec-
tor at 215  nm and 285  nm. Phenolic compounds were 
analysed with Chromeleon 6.8 software on a Dionex 
3000 System with UV detector at 285 nm equipped with 
a Waters XSelect C18 Column (4.6 × 250  mm). Mobile 
phases used for elution was water (phase A) and acetoni-
trile (phase B) at a flow rate of 0.7  mL   min−1 [55]. The 
 SO2 content was measured via the Ripper titration [56] 
at the Department of Wine Biotechnology, whereas mag-
nesium oxide (MgO) content via ICP-MS, at the Depart-
ment of Geology, Stellenbosch University.
Calculations and statistical analysis
All experiments were conducted in triplicate. Data 
were analysed using Microsoft Excel data analysis tools, 
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whereby triplicate values were subjected to analysis of 
variance (ANOVA) and p < 0.05 was considered sig-
nificant for this study. Ethanol yields (YE/TS) were cal-
culated as final ethanol (g  L−1) divided by total sugar 
(g  L−1). Ethanol productivity was calculated as ethanol 
concentration (g  L−1) divided by fermentation time 
(h). The metabolic yield of ethanol was calculated as 
final ethanol concentration (g  L−1) divided by total 
consumed sugar (g  L−1) throughout the fermentation, 
compared to the theoretical maximum metabolic yield 
of 0.51 (g  g−1) expressed as a fraction (%). The growth 
rate as µmax was determined during the exponential 
growth phase by plotting the natural logarithm values 
as a function of time.
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